Shuang Cai

6.1k total citations
60 papers, 1.8k citations indexed

About

Shuang Cai is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuang Cai has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuang Cai's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and RNA modifications and cancer (5 papers). Shuang Cai is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and RNA modifications and cancer (5 papers). Shuang Cai collaborates with scholars based in China, United States and Canada. Shuang Cai's co-authors include M. Laird Forrest, Taryn R. Bagby, Mark S. Cohen, Yumei Xie, Qiuhong Yang, Neal M. Davies, Mauricio Oberti, Ratna R. Thangudu, Subha Madhavan and Karen A. Ketchum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shuang Cai

56 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuang Cai China 23 815 370 335 309 248 60 1.8k
Chao Qin China 24 672 0.8× 424 1.1× 370 1.1× 231 0.7× 177 0.7× 69 1.5k
Ye Liang China 25 821 1.0× 350 0.9× 250 0.7× 259 0.8× 172 0.7× 76 1.9k
Jooho Park South Korea 26 920 1.1× 622 1.7× 760 2.3× 404 1.3× 199 0.8× 73 2.1k
Sang Kyoon Kim South Korea 26 644 0.8× 473 1.3× 393 1.2× 258 0.8× 102 0.4× 55 1.7k
Chalet Tan United States 26 1.2k 1.4× 336 0.9× 384 1.1× 351 1.1× 137 0.6× 47 2.3k
Amit Singh United States 15 608 0.7× 604 1.6× 482 1.4× 218 0.7× 98 0.4× 15 1.3k
Zhiwen Yao China 13 551 0.7× 452 1.2× 339 1.0× 498 1.6× 194 0.8× 32 1.9k
Marta Truffi Italy 24 704 0.9× 405 1.1× 394 1.2× 379 1.2× 122 0.5× 69 1.7k
Imran Vhora India 21 877 1.1× 617 1.7× 386 1.2× 325 1.1× 148 0.6× 25 1.8k
Houría Boulaiz Spain 28 928 1.1× 383 1.0× 406 1.2× 332 1.1× 84 0.3× 84 2.0k

Countries citing papers authored by Shuang Cai

Since Specialization
Citations

This map shows the geographic impact of Shuang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuang Cai more than expected).

Fields of papers citing papers by Shuang Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuang Cai. The network helps show where Shuang Cai may publish in the future.

Co-authorship network of co-authors of Shuang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Shuang Cai. A scholar is included among the top collaborators of Shuang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuang Cai. Shuang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hao, Shuang Cai, Qu Li, et al.. (2025). Chitosan-based therapeutic approaches for gastrointestinal malignancies: A review of novel drug delivery platforms and theragnostic systems. Industrial Crops and Products. 235. 121608–121608.
3.
Guo, Bo, Shuang Cai, Wen Li, et al.. (2022). Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription. Current Cancer Drug Targets. 22(5). 414–425. 3 indexed citations
4.
Wang, Jianqun, Xiaojing Wang, Yanhua Guo, et al.. (2021). Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression. SHILAP Revista de lepidopterología. 11(11). e588–e588. 38 indexed citations
5.
Groer, Chad E., Ti Zhang, Shuang Cai, et al.. (2020). Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent. Molecular Pharmaceutics. 17(11). 4334–4345. 23 indexed citations
6.
Cai, Shuang, Jie Lin, Wenhua Zhu, et al.. (2018). Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Journal of Clinical Neuroscience. 57. 13–19. 22 indexed citations
7.
Feng, Yu, Shuang Cai, Guoliang Xiong, et al.. (2017). Sensitive Detection of DNA Lesions by Bulge-Enhanced Highly Specific Coamplification at Lower Denaturation Temperature Polymerase Chain Reaction. Analytical Chemistry. 89(15). 8084–8091. 17 indexed citations
9.
Zhan, Xiaohui, Qiangying Yi, Shuang Cai, et al.. (2017). Polymer-entanglement-driven coassembly of hybrid superparamagnetic nanoparticles: Tunable structures and flexible functionalization. Journal of Colloid and Interface Science. 508. 263–273. 5 indexed citations
10.
Edwards, Nathan, Mauricio Oberti, Ratna R. Thangudu, et al.. (2015). The CPTAC Data Portal: A Resource for Cancer Proteomics Research. Journal of Proteome Research. 14(6). 2707–2713. 311 indexed citations
12.
Cai, Shuang, et al.. (2014). Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. Journal of drug targeting. 22(7). 648–657. 45 indexed citations
13.
Shi, Jing, Jianhua Tong, Shuang Cai, Xiujuan Qu, & Yunpeng Liu. (2013). Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis. Experimental and Therapeutic Medicine. 6(2). 435–444. 7 indexed citations
14.
Wang, Lei, et al.. (2013). Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis. Diagnostic Pathology. 8(1). 180–180. 23 indexed citations
16.
Luan, Yepeng, et al.. (2011). A sensitive near-infrared fluorescent probe for caspase-mediated apoptosis: Synthesis and application in cell imaging. Drug Discoveries & Therapeutics. 5(5). 220–226. 9 indexed citations
17.
Yang, Qiuhong, Huizhong Cui, Shuang Cai, Xinmai Yang, & M. Laird Forrest. (2011). In vivo photoacoustic imaging of chemotherapy-induced apoptosis in squamous cell carcinoma using a near-infrared caspase-9 probe. Journal of Biomedical Optics. 16(11). 116026–116026. 21 indexed citations
18.
Cai, Shuang, Yumei Xie, Neal M. Davies, Mark S. Cohen, & M. Laird Forrest. (2010). Carrier-based Intralymphatic Cisplatin Chemotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck. Therapeutic Delivery. 1(2). 237–245. 20 indexed citations
19.
Cai, Shuang, Yumei Xie, Neal M. Davies, Mark S. Cohen, & M. Laird Forrest. (2009). Pharmacokinetics and Disposition of a Localized Lymphatic Polymeric Hyaluronan Conjugate of Cisplatin in Rodents. Journal of Pharmaceutical Sciences. 99(6). 2664–2671. 46 indexed citations
20.
Cohen, Mark S., Shuang Cai, Yumei Xie, & M. Laird Forrest. (2009). A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo. The American Journal of Surgery. 198(6). 781–786. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026